Description
VetPlus by Philozon is a state-of-the-art veterinary ozone therapy device designed to deliver precise, safe, and effective ozone treatments for animals of all sizes. Engineered with advanced photometric calibration and high-quality ozone-resistant materials, VetPlus ensures accurate concentration control and maximum therapeutic performance in every procedure.
With a wide concentration range from 1 to 65 µg/mL, digital oxygen flow adjustment, and a user-friendly 4.3” touch screen, VetPlus adapts perfectly to diverse veterinary treatment protocols — from wound care to systemic applications.
Key Features
• Wide Ozone Concentration Range
Delivers 1–65 µg/mL, enabling precise ozone dosing for multiple veterinary applications such as wound healing, infection control, anti-inflammatory therapy, and more.
• Digital Oxygen Flow Control
Adjustable flow from 0.2 to 1.2 L/min, ensuring accurate and stable ozone production tailored to each treatment.
• 4.3” Color Touch Screen
Modern, intuitive interface for easy navigation and quick selection of clinical settings.
• ECO Mode
Reduces oxygen consumption and energy usage, increasing efficiency during continuous treatments.
• Integrated Ozone Destructor
Neutralizes excess ozone gas into oxygen, providing safer operation for both veterinarians and animals.
• Premium Ozone-Resistant Components
Built with anodized aluminum and borosilicate glass for long-term durability and maximum chemical resistance.
• Compact & Lightweight Design
Only 3.6 kg, making it ideal for mobile veterinarians and multi-room clinics.
• Automatic System Cleaning
Internal automatic cleaning system extends device lifespan and maintains consistent performance.
Clinical Applications
-
Wound healing and tissue regeneration
-
Antimicrobial therapy (bacteria, fungi, viruses)
-
Anti-inflammatory treatments
-
Ozone insufflation (as permitted)
-
Ozonated fluids for internal or external use
-
Pain management
-
Dermatological conditions
-
Orthopedic and post-surgical recovery





Reviews
There are no reviews yet.